Pub. Date : 2020 Jan
PMID : 31506605
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Preclinical studies using multiple in vitro nAR-negative BCa cell lines and an in vivo mouse model all demonstrated that targeting this newly identified DHT/mAR-SLC39A9/Galphai/MAPK/MMP9 signaling with small molecules mAR-SLC39A9-shRNA or Galphai-shRNA, and not the classic antiandrogens including enzalutamide, bicalutamide, or hydroxyflutamide, could suppress nAR-negative BCa cell invasion. | nar | solute carrier family 39 (zinc transporter), member 9 | Mus musculus |
2 | Preclinical studies using multiple in vitro nAR-negative BCa cell lines and an in vivo mouse model all demonstrated that targeting this newly identified DHT/mAR-SLC39A9/Galphai/MAPK/MMP9 signaling with small molecules mAR-SLC39A9-shRNA or Galphai-shRNA, and not the classic antiandrogens including enzalutamide, bicalutamide, or hydroxyflutamide, could suppress nAR-negative BCa cell invasion. | nar | solute carrier family 39 (zinc transporter), member 9 | Mus musculus |